Driven by challenge, fuelled by collaboration

In 2015, Gilead and Galapagos formed a global partnership. In 2019, we further solidified our commitment, entering into a 10-year global research and development collaboration. With Gilead’s history of dismantling diseases and the unique Galapagos drug discovery platform, we believe we can make an impact on inflammation and improve the lives of patients living with RA.

Gilead and Galapagos: Finding answers together
For news on the partnership’s continuing innovation in RA, subscribe here.